COMMUNIQUÉS West-GlobeNewswire

BioSyent Releases Financial Results for Q2 and H1 2026
20/08/2026
MISSISSAUGA, Ontario, Aug. 20, 2026 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its consolidated financial results for the three months (Q2), six months (H1), and trailing twelve [...]
Aveanna Announces Launch of Secondary Offering of Common Stock
20/08/2026
ATLANTA, Aug. 20, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, [...]
The Ensign Group Increases Credit Facility to $800 Million and Extends Maturity
20/08/2026
SAN JUAN CAPISTRANO, Calif., Aug. 20, 2026 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living [...]
Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
20/08/2026
WALTHAM, Mass., Aug. 20, 2026 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc . (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular [...]
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
20/08/2026
CONSHOHOCKEN, Pa., Aug. 20, 2026 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated [...]
iSpecimen Completes Large-Scale International Cancer Research Order; Samples Shipped Within Three Weeks
20/08/2026
Woburn, MA, Aug. 20, 2026 (GLOBE NEWSWIRE) -- iSpecimen, a provider of human biospecimens, recently completed an international cancer research project involving hundreds of cancer blood specimens, with the samples [...]
NEXGEL ANNOUNCES LEADERSHIP TRANSITION AND STRATEGIC REVIEW INITIATIVE
20/08/2026
LANGHORNE, Pa., Aug. 20, 2026 (GLOBE NEWSWIRE) -- NEXGEL, Inc. ("NEXGEL" or the "Company") (NASDAQ: “NXGL”) today announced a series of leadership, governance and strategic initiatives designed to strengthen operational [...]
Adaptin Bio Announces Opening of Enrollment in a Phase 1 Clinical Trial Evaluating Treatment of Malignant Brain Tumors with APTN-101
20/08/2026
APTN-101’s unique mechanism of action is designed to overcome the limitations for effective treatment of malignant brain tumors by enhancing the transport of therapies across the blood-brain barrier and selectively [...]
Tilray renforce son leadership mondial dans le cannabis médical grâce à une forte hausse de sa production pour répondre à la demande internationale
20/08/2026
L’extension des capacités de culture au Québec et au Portugal consolide la plateforme mondiale de cannabis de Tilray, qui porte sa capacité annuelle totale à environ 275 tonnes métriques pour accompagner l’essor de la [...]
DirectMax Details Eligibility Screening and Safety-Disclosure Process Across Direct Meds Telehealth Platform
20/08/2026
Direct Meds details new DirectMax eligibility screening, medication-interaction disclosure and compounded-formulation information covering sildenafil, tadalafil and apomorphine, delivered through independent provider [...]
Integrity Urgent Care Clinic Opens in Speegleville, Texas
20/08/2026
Speegleville’s newest urgent care clinic celebrates opening with $5,000 donation to China Spring High School band Key facts of this press release: Integrity Urgent Care opened a clinic in Speegleville, Texas, on Aug. 17 [...]
Ipsen - July 2026 - Monthly information relative to the total number of voting rights and shares composing the share capital
20/08/2026
Monthly information relative to the total number of voting rights and shares composing the share capital (in accordance with Article L.233-8 II of the French Commercial Code and Article 223-16 of the General Regulation [...]
Ipsen - Juillet 2026 - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
20/08/2026
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social (conformément à l’article L.233-8 II du Code de commerce et à l’article 223-16 du Règlement Général de l’ [...]
Comprehensive Healthcare Expands Bridges Evaluation & Treatment Facility to Offer Secure Detox Services
20/08/2026
The facility is one of only a few in Washington state providing medically monitored inpatient withdrawal management YAKIMA, Wash., Aug. 20, 2026 (GLOBE NEWSWIRE) -- As the Yakima Valley continues to strengthen its [...]
Roche’s US subsidiary Genentech announces manufacturing expansion in the United States
20/08/2026
New facility in Hillsboro, Oregon for the assembly of injectable medicines and delivery devices will further advance end-to-end U.S. drug manufacturing capabilities. Approximately $750 million investment will double the [...]
Vivos Therapeutics Opens New Sleep Testing and Treatment Facility in Nevada to Meet Rapidly Growing Patient Demand for Sleep Apnea Testing and Treatment
20/08/2026
New Location Expected to More Than Double Annual Revenue Production Capacity to Over $10 Million Official Grand Opening Slated for August 27 in Henderson, Nevada With Prominent Industry Opinion Leaders, Sleep Physicians [...]
PETVIVO HOLDINGS ANNOUNCES NAME CHANGE OF HUMAN SUBSIDIARY TO SOMATRIX TECHNOLOGIES, INC. AND EXPANDS FOCUS ON HUMAN HEALTH INNOVATION
20/08/2026
New Human Health Subsidiary to Advance Development of Innovative Biomaterial Technologies and Potential New Products for Human and Animal Health MINNEAPOLIS, Aug. 20, 2026 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. ( [...]
DAZED INC. ACCELERATES GROWTH INITIATIVES: REACHES 13 LOCATIONS WITH DALLAS EXPANSION, ANNOUNCES Q4 STOCK BUYBACK, AND REPORTS STRONG Q2 2026 FINANCIALS
20/08/2026
Dazed Inc. re-releases corporate update highlighting 13 store locations, robust Q2 financials, upcoming Q4 stock buyback, and new digital web platforms. Austin, TX, Aug. 20, 2026 (GLOBE NEWSWIRE) -- FOR IMMEDIATE [...]
Channel Medsystems Series C, led by InnovaHealth Partners, LP Reaches $30 Million as the Company Accelerates Commercial Expansion of Cerene®
20/08/2026
Investment supports the continued growth of the Cerene® Cryotherapy platform, enabling greater access for women suffering from heavy menstrual bleeding and dysmenorrhea BERKELEY, Calif., Aug. 20, 2026 (GLOBE NEWSWIRE [...]

Pages